Back to top

Valic Co I Health Sciences Fd: (MF: VCHSX)

(MF) As of Apr 15, 2014 06:06 PM ET

 Add to portfolio

$19.56 USD

+0.14 (0.72%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 5.88
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for VCHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Buy 1
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 36.68
Net Assets (Mil $) 3/31/2014 523.89
%Turnover 3/31/2014 16.00

Allocation

% of Portfolio
Large Growth 22.22
Large Value 0.00
Small Growth 3.85
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 32.35
High Yield Bond 17.78

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 45.59
Services 17.46
Finance 11.12
Other 9.36
Industrial Cyclical 5.59
Retail Trade 5.10
Technology 4.83
Non-Durable 0.95

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.69 40.31
ALEXION PHARMACEUTICALS I 4.31 22.58
BIOGEN IDEC INC 3.31 17.34
PHARMACYCLICS INC 3.03 15.88
UNITEDHEALTH GROUP INC 2.99 15.66
VALEANT PHARMACEUTICALS 2.80 14.69
INCYTE PHARMACEUTICALS IN 2.75 14.41
AETNA INC 2.19 11.48
ABBVIE INC 2.13 11.18

Stock Holding % of Net Assets

As Of 11/30/2013
Total Issues 161
Avg. P/E 27.74
Avg. P/Book 4.47
Avg. EPS Growth 16.46
Avg. Market Value (Mil $) 33,987

Risk

3 Year 5 Year 10 Year
Beta 0.94 0.84 NA
Alpha 12.64 10.96 NA
R Squared 0.58 0.57 NA
Std. Dev. 15.58 15.52 NA
Sharpe 1.86 2.00 NA